{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:21:35Z","timestamp":1773710495996,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jpag.2012.05.016","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T01:56:16Z","timestamp":1346032576000},"page":"347-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-acting Reversible Contraceptive Methods for Adolescents with Chronic Medical Problems"],"prefix":"10.1016","volume":"25","author":[{"given":"Amy G.","family":"Bryant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen S.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subasri","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2012.05.016_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10935-008-0137-9","article-title":"Pediatricians' role and practices regarding provision of guidance about sexual risk reduction to parents","volume":"29","author":"Miller","year":"2008","journal-title":"J Prim Prev"},{"key":"10.1016\/j.jpag.2012.05.016_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1363\/3809006","article-title":"Disparities in rates of unintended pregnancy in the United States, 1994 and 2001","volume":"38","author":"Finer","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.jpag.2012.05.016_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpedi.1997.02170400076014","article-title":"Sexual health contraceptive needs of adolescents with chronic conditions","volume":"151","author":"Blum","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpag.2012.05.016_bib4","series-title":"Contraceptive Technology","author":"Hatcher","year":"2007"},{"issue":"2 Pt 1","key":"10.1016\/j.jpag.2012.05.016_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0b013e31820563d3","article-title":"One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives","volume":"117","author":"Raine","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.05.016_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0749-3797(01)00316-6","article-title":"A village would be nice but\u2026it takes a long-acting contraceptive to prevent repeat adolescent pregnancies","volume":"21","author":"Stevens-Simon","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jpag.2012.05.016_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0010-7824(94)90062-0","article-title":"Contraceptive outcomes among post-partum and post-abortal adolescents","volume":"50","author":"Blumenthal","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.05.016_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0002-9378(12)91818-9","article-title":"Contraception for patients with psychiatric or medical disorders","volume":"170","author":"Jones","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.05.016_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.contraception.2009.06.005","article-title":"Forgettable contraception","volume":"80","author":"Grimes","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.05.016_bib10","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/AOG.0b013e3181c6f965","article-title":"ACOG Committee Opinion No. 450: Increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.05.016_bib11","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.AOG.0000291575.93944.1a","article-title":"ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents","volume":"110","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.05.016_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jadohealth.2006.11.005","article-title":"Long-acting hormonal contraceptives\u2013indispensable in preventing teen pregnancy","volume":"40","author":"Kaunitz","year":"2007","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jpag.2012.05.016_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.contraception.2010.04.041","article-title":"Rates of continuation and expulsion of intrauterine contraception at 12 months in nulliparous and adolescent women","volume":"82","author":"Madden","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.05.016_bib14","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.contraception.2011.05.010","article-title":"Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women","volume":"84","author":"Behringer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.05.016_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.contraception.2011.03.001","article-title":"Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project","volume":"84","author":"Mestad","year":"2011","journal-title":"Contraception"},{"issue":"RR-4","key":"10.1016\/j.jpag.2012.05.016_bib16","first-page":"1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2010","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jpag.2012.05.016_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/AOG.0b013e3181ae9c64","article-title":"del Carmen Cravioto M: Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review","volume":"114","author":"Culwell","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.05.016_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/03009749109096822","article-title":"Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE","volume":"20","author":"Julkunen","year":"1991","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jpag.2012.05.016_bib19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780250603","article-title":"Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus","volume":"25","author":"Jungers","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpag.2012.05.016_bib20","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2012.05.016_bib21","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"Sanchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2012.05.016_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10067-007-0721-z","article-title":"Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies","volume":"27","author":"Choojitarom","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jpag.2012.05.016_bib23","first-page":"1683","article-title":"Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies","volume":"29","author":"Chopra","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpag.2012.05.016_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1546-0096-8-10","article-title":"Contraception for adolescents with lupus","volume":"8","author":"Tesher","year":"2010","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jpag.2012.05.016_bib25","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/hrt.2006.095240","article-title":"Risks of contraception and pregnancy in heart disease","volume":"92","author":"Thorne","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jpag.2012.05.016_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2217\/17455057.3.6.711","article-title":"Contraception in women with cardiac disease","volume":"3","author":"Hudsmith","year":"2007","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.jpag.2012.05.016_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11886-009-0043-7","article-title":"Choosing the best contraceptive method for the adult with congenital heart disease","volume":"11","author":"Silversides","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jpag.2012.05.016_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1783\/147118906776276486","article-title":"Pregnancy and contraception in heart disease and pulmonary arterial hypertension","volume":"32","author":"Thorne","year":"2006","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.jpag.2012.05.016_bib29","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.athoracsur.2011.05.088","article-title":"A growing problem: maternal death and peripartum complications are higher in women with grown-up congenital heart disease","volume":"92","author":"Karamlou","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jpag.2012.05.016_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.contraception.2005.08.010","article-title":"Progestogen-only contraceptive use among women with sickle cell anemia: a systematic review","volume":"73","author":"Legardy","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.05.016_bib31","first-page":"CD006261","article-title":"Steroid hormones for contraception in women with sickle cell disease","author":"Manchikanti","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpag.2012.05.016_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(97)00156-X","article-title":"Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients","volume":"56","author":"de Abood","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.05.016_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(82)90320-8","article-title":"Medroxyprogesterone acetate and homozygous sickle-cell disease","volume":"2","author":"De Ceulaer","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jpag.2012.05.016_bib34","first-page":"3","article-title":"Contraception and sickle cell disease","volume":"28","author":"Howard","year":"1994","journal-title":"IPPF Med Bull"},{"key":"10.1016\/j.jpag.2012.05.016_bib35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1365-2141.1999.01255.x","article-title":"Red cell deformability in oral contraceptive pill users with sickle cell anaemia","volume":"104","author":"Yoong","year":"1999","journal-title":"Br J Haematol"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108331881200099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108331881200099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:39:23Z","timestamp":1761053963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108331881200099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S108331881200099X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2012.05.016","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting Reversible Contraceptive Methods for Adolescents with Chronic Medical Problems","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2012.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}